Immune to Cancer: The CRI Blog
-
The Impact of Immune Monitoring for the Early Detection of Cancer
Cancer prevention and early detection are crucial in our fight against this devastating disease. While the thought… -
Tecelra® Receives FDA Approval: A New Milestone in Cancer Treatment
On August 2, 2024, the U.S Food and Drug Administration (FDA) approved Tecelra® (afamitresgene autoleucel), a gene… -
CRI’s 5th Annual Wear White Luncheon Raises Over $40,000
On Thursday, June 20, 2024, the Cancer Research Institute (CRI) celebrated its fifth annual Wear White Luncheon,… -
Keytruda Receives 40th FDA Approval
This week marked a significant milestone in the fight against cancer. On June 17, the FDA approved…